E-LIB Suche - Ergebnisse für: Milicevic, Zvonko

1

Effects of Tirzepatide vs Semaglutide on β-Cell Function, I..:

Mather, Kieren J ; Mari, Andrea ; Heise, Tim...
The Journal of Clinical Endocrinology & Metabolism. , 2024

Link: https://doi.org/10.1210/..

2

New improved radiometabolite analysis method for [18F]FTHA ..:

Aarnio, Richard ; Kirjavainen, Anna ; Rajander, Johan...
EJNMMI Research. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, fo..:

Rosenstock, Julio ; Frias, Juan ; Jastreboff, Ania M...
The Lancet. 402 (2023) 10401 - p. 529-544 , 2023

Link: https://doi.org/10.1016/..

4

Improvements in post‐challenge lipid response following tir..:

Mather, Kieren J. ; Coskun, Tamer ; Pratt, Edward J....
Diabetes, Obesity and Metabolism. 26 (2023) 2 - p. 785-789 , 2023

Link: https://doi.org/10.1111/..

5

The novel GIP, GLP‐1 and glucagon receptor agonist retatrut..:

Urva, Shweta ; O'Farrell, Libbey ; Du, Yu...
Diabetes, Obesity and Metabolism. 25 (2023) 9 - p. 2784-2788 , 2023

Link: https://doi.org/10.1111/..

6

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor..:

Coskun, Tamer ; Urva, Shweta ; Roell, William C....
Cell Metabolism. 34 (2022) 9 - p. 1234-1247.e9 , 2022

Link: https://doi.org/10.1016/..

7

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor..:

Urva, Shweta ; Coskun, Tamer ; Loh, Mei Teng...
The Lancet. 400 (2022) 10366 - p. 1869-1881 , 2022

Link: https://doi.org/10.1016/..

8

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Be..:

Thomas, Melissa K ; Nikooienejad, Amir ; Bray, Ross...
The Journal of Clinical Endocrinology & Metabolism. 106 (2020) 2 - p. 388-396 , 2020

Link: https://doi.org/10.1210/..

9

Efficacy and tolerability of tirzepatide, a dual glucose‐de..:

Frias, Juan Pablo ; Nauck, Michael A. ; Van, Joanna...
Diabetes, Obesity and Metabolism. 22 (2020) 6 - p. 938-946 , 2020

Link: https://doi.org/10.1111/..

10

OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3...:

Cox, David A ; Woodward, Brad ; Milicevic, Zvonko...
Journal of the Endocrine Society. 4 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1210/..

11

Efficacy and safety of an expanded dulaglutide dose range: ..:

Frias, Juan P. ; Wynne, Alan G. ; Matyjaszek‐Matuszek, Beata...
Diabetes, Obesity and Metabolism. 21 (2019) 9 - p. 2048-2057 , 2019

Link: https://doi.org/10.1111/..

12

Effect of once‐weekly dulaglutide versus insulin glargine i..:

Giorgino, Francesco ; Yu, Maria ; Haupt, Axel..
Diabetes, Obesity and Metabolism. 21 (2019) 11 - p. 2570-2575 , 2019

Link: https://doi.org/10.1111/..

13

Dulaglutide treatment results in effective glycaemic contro..:

Pozzilli, Paolo ; Leslie, Richard D. ; Peters, Anne L....
Diabetes, Obesity and Metabolism. 20 (2018) 6 - p. 1490-1498 , 2018

Link: https://doi.org/10.1111/..

14

Response to the comment on: "Dulaglutide treatment results ..:

Leslie, Richard D. ; Pozzilli, Paolo ; Peters, Anne L....
Diabetes, Obesity and Metabolism. 20 (2018) 9 - p. 2319-2320 , 2018

Link: https://doi.org/10.1111/..

15

Efficacy and safety of LY3298176, a novel dual GIP and GLP-..:

Frias, Juan Pablo ; Nauck, Michael A ; Van, Joanna...
The Lancet. 392 (2018) 10160 - p. 2180-2193 , 2018

Link: https://doi.org/10.1016/..